speb/financial-data huggingface dataset:
BCTX cash_flow (quarterly, 2025-01-31) — Change In Accrued Expense: -177069.00
BCTX cash_flow (quarterly, 2025-01-31) — Change In Payable: 769271.00
BCTX cash_flow (quarterly, 2025-01-31) — Change In Payables And Accrued Expense: 592202.00
BCTX cash_flow (quarterly, 2025-01-31) — Change In Prepaid Assets: 291527.00
BCTX cash_flow (quarterly, 2025-01-31) — Change In Receivables: 277911.00
BCTX cash_flow (quarterly, 2025-01-31) — Change In Working Capital: 870113.00
BCTX cash_flow (quarterly, 2025-01-31) — Changes In Cash: -778611.00
BCTX balance_sheet (quarterly, 2025-01-31) — Common Stock: 85451119.00
BCTX balance_sheet (quarterly, 2025-01-31) — Common Stock Equity: 3602922.00
BCTX cash_flow (quarterly, 2025-01-31) — Common Stock Issuance: 4688847.00
BCTX balance_sheet (quarterly, 2025-01-31) — Current Accrued Expenses: 227599.00
BCTX balance_sheet (quarterly, 2025-01-31) — Current Assets: 7162573.00
BCTX balance_sheet (quarterly, 2025-01-31) — Current Liabilities: 5230838.00
BCTX cash_flow (quarterly, 2025-01-31) — Depreciation: 22839.00
BCTX cash_flow (quarterly, 2025-01-31) — Depreciation Amortization Depletion: 26657.00
BCTX cash_flow (quarterly, 2025-01-31) — Depreciation And Amortization: 26657.00
BCTX balance_sheet (quarterly, 2025-01-31) — Derivative Product Liabilities: 905838.00
BCTX income_statement (quarterly, 2025-01-31) — Diluted Average Shares: 269957.00
BCTX income_statement (quarterly, 2025-01-31) — Diluted EPS: -23.31
BCTX income_statement (quarterly, 2025-01-31) — Diluted NI Availto Com Stockholders: -6291420.00
BCTX income_statement (quarterly, 2025-01-31) — EBIT: -7169443.00
BCTX income_statement (quarterly, 2025-01-31) — EBITDA: -7142786.00
BCTX income_statement (quarterly, 2025-01-31) — Earnings From Equity Interest: -42584.00
BCTX cash_flow (quarterly, 2025-01-31) — Earnings Losses From Equity Investments: 42584.00
BCTX cash_flow (quarterly, 2025-01-31) — End Cash Position: 5013654.00
BCTX cash_flow (quarterly, 2025-01-31) — Financing Cash Flow: 5216611.00
BCTX cash_flow (quarterly, 2025-01-31) — Free Cash Flow: -5920222.00
BCTX cash_flow (quarterly, 2025-01-31) — Gain Loss On Investment Securities: -806841.00
BCTX income_statement (quarterly, 2025-01-31) — Gain On Sale Of Security: 827367.00
BCTX balance_sheet (quarterly, 2025-01-31) — Gains Losses Not Affecting Retained Earnings: -138684.00
BCTX income_statement (quarterly, 2025-01-31) — General And Administrative Expense: 1484666.00
BCTX balance_sheet (quarterly, 2025-01-31) — Goodwill And Other Intangible Assets: 192160.00
BCTX income_statement (quarterly, 2025-01-31) — Interest Income: 46832.00
BCTX income_statement (quarterly, 2025-01-31) — Interest Income Non Operating: 46832.00
BCTX balance_sheet (quarterly, 2025-01-31) — Invested Capital: 3602922.00
BCTX cash_flow (quarterly, 2025-01-31) — Investing Cash Flow: -75000.00
BCTX balance_sheet (quarterly, 2025-01-31) — Investments And Advances: 454391.00
BCTX balance_sheet (quarterly, 2025-01-31) — Investmentsin Subsidiariesat Cost: 454391.00
BCTX cash_flow (quarterly, 2025-01-31) — Issuance Of Capital Stock: 4688847.00
BCTX balance_sheet (quarterly, 2025-01-31) — Long Term Equity Investment: 454391.00
BCTX balance_sheet (quarterly, 2025-01-31) — Minority Interest: -376031.00
BCTX income_statement (quarterly, 2025-01-31) — Minority Interests: 46408.00
BCTX cash_flow (quarterly, 2025-01-31) — Net Business Purchase And Sale: -75000.00
BCTX cash_flow (quarterly, 2025-01-31) — Net Common Stock Issuance: 4688847.00
BCTX income_statement (quarterly, 2025-01-31) — Net Income: -6291420.00
BCTX income_statement (quarterly, 2025-01-31) — Net Income Common Stockholders: -6291420.00
BCTX income_statement (quarterly, 2025-01-31) — Net Income Continuous Operations: -6337828.00
BCTX income_statement (quarterly, 2025-01-31) — Net Income From Continuing And Discontinued Operation: -6291420.00
BCTX income_statement (quarterly, 2025-01-31) — Net Income From Continuing Operation Net Minority Interest: -6291420.00
BCTX cash_flow (quarterly, 2025-01-31) — Net Income From Continuing Operations: -6337828.00
BCTX income_statement (quarterly, 2025-01-31) — Net Income Including Noncontrolling Interests: -6337828.00
BCTX income_statement (quarterly, 2025-01-31) — Net Interest Income: 46832.00
BCTX income_statement (quarterly, 2025-01-31) — Net Non Operating Interest Income Expense: 46832.00
BCTX balance_sheet (quarterly, 2025-01-31) — Net PPE: 342497.00
BCTX balance_sheet (quarterly, 2025-01-31) — Net Tangible Assets: 3410762.00
BCTX balance_sheet (quarterly, 2025-01-31) — Non Current Prepaid Assets: 1211946.00
BCTX income_statement (quarterly, 2025-01-31) — Normalized EBITDA: -7970153.00
BCTX income_statement (quarterly, 2025-01-31) — Normalized Income: -7118787.00
BCTX cash_flow (quarterly, 2025-01-31) — Operating Cash Flow: -5920222.00
BCTX cash_flow (quarterly, 2025-01-31) — Operating Gains Losses: -764257.00
BCTX income_statement (quarterly, 2025-01-31) — Operating Income: -7169443.00
BCTX income_statement (quarterly, 2025-01-31) — Operating Revenue: 0.00
BCTX balance_sheet (quarterly, 2025-01-31) — Ordinary Shares Number: 294694.00
BCTX balance_sheet (quarterly, 2025-01-31) — Other Equity Adjustments: -138684.00
BCTX balance_sheet (quarterly, 2025-01-31) — Other Equity Interest: 15827779.00
BCTX income_statement (quarterly, 2025-01-31) — Other Gand A: 1484666.00
BCTX income_statement (quarterly, 2025-01-31) — Other Income Expense: 784783.00
BCTX balance_sheet (quarterly, 2025-01-31) — Payables: 5003239.00
BCTX balance_sheet (quarterly, 2025-01-31) — Payables And Accrued Expenses: 5230838.00
BCTX income_statement (quarterly, 2025-01-31) — Pretax Income: -6337828.00
BCTX cash_flow (quarterly, 2025-01-31) — Proceeds From Stock Option Exercised: 527764.00
BCTX cash_flow (quarterly, 2025-01-31) — Purchase Of Business: -75000.00
BCTX balance_sheet (quarterly, 2025-01-31) — Receivables: 2148919.00
BCTX income_statement (quarterly, 2025-01-31) — Reconciled Depreciation: 26657.00
BCTX income_statement (quarterly, 2025-01-31) — Research And Development: 5684777.00
BCTX balance_sheet (quarterly, 2025-01-31) — Retained Earnings: -97537292.00
BCTX income_statement (quarterly, 2025-01-31) — Selling General And Administration: 1484666.00
BCTX balance_sheet (quarterly, 2025-01-31) — Share Issued: 294694.00
BCTX cash_flow (quarterly, 2025-01-31) — Stock Based Compensation: 285093.00
BCTX balance_sheet (quarterly, 2025-01-31) — Stockholders Equity: 3602922.00
BCTX balance_sheet (quarterly, 2025-01-31) — Tangible Book Value: 3410762.00
BCTX income_statement (quarterly, 2025-01-31) — Tax Effect Of Unusual Items: 0.00
BCTX income_statement (quarterly, 2025-01-31) — Tax Rate For Calcs: 0.00
BCTX balance_sheet (quarterly, 2025-01-31) — Total Assets: 9363567.00
BCTX balance_sheet (quarterly, 2025-01-31) — Total Capitalization: 3602922.00
BCTX balance_sheet (quarterly, 2025-01-31) — Total Equity Gross Minority Interest: 3226891.00
BCTX income_statement (quarterly, 2025-01-31) — Total Expenses: 7169443.00
BCTX balance_sheet (quarterly, 2025-01-31) — Total Liabilities Net Minority Interest: 6136676.00
BCTX balance_sheet (quarterly, 2025-01-31) — Total Non Current Assets: 2200994.00
BCTX balance_sheet (quarterly, 2025-01-31) — Total Non Current Liabilities Net Minority Interest: 905838.00
BCTX income_statement (quarterly, 2025-01-31) — Total Operating Income As Reported: -7169443.00
BCTX income_statement (quarterly, 2025-01-31) — Total Unusual Items: 827367.00
BCTX income_statement (quarterly, 2025-01-31) — Total Unusual Items Excluding Goodwill: 827367.00
BCTX balance_sheet (quarterly, 2025-01-31) — Working Capital: 1931735.00
BCTX income_statement (quarterly, 2025-04-30) — +Operating Expense: 6328255.00
BCTX income_statement (quarterly, 2025-04-30) — +Total Revenue: 0.00
BCTX balance_sheet (quarterly, 2025-04-30) — Accounts Payable: 3279204.00
BCTX balance_sheet (quarterly, 2025-04-30) — Accounts Receivable: 2324945.00
BCTX cash_flow (quarterly, 2025-04-30) — Amortization Cash Flow: 3817.00
BCTX cash_flow (quarterly, 2025-04-30) — Amortization Of Intangibles: 3817.00
BCTX income_statement (quarterly, 2025-04-30) — Basic Average Shares: 373067.00
BCTX income_statement (quarterly, 2025-04-30) — Basic EPS: -16.42
BCTX cash_flow (quarterly, 2025-04-30) — Beginning Cash Position: 5013654.00
BCTX balance_sheet (quarterly, 2025-04-30) — Capital Stock: 94022525.00
BCTX balance_sheet (quarterly, 2025-04-30) — Cash And Cash Equivalents: 12460253.00
BCTX balance_sheet (quarterly, 2025-04-30) — Cash Cash Equivalents And Short Term Investments: 12460253.00
BCTX cash_flow (quarterly, 2025-04-30) — Cash Flow From Continuing Financing Activities: 14714376.00
BCTX cash_flow (quarterly, 2025-04-30) — Cash Flow From Continuing Investing Activities: -105000.00
BCTX cash_flow (quarterly, 2025-04-30) — Cash Flow From Continuing Operating Activities: -7162777.00
BCTX cash_flow (quarterly, 2025-04-30) — Change In Account Payable: -1724035.00
BCTX cash_flow (quarterly, 2025-04-30) — Change In Accrued Expense: 823830.00
BCTX cash_flow (quarterly, 2025-04-30) — Change In Payable: -1724035.00
BCTX cash_flow (quarterly, 2025-04-30) — Change In Payables And Accrued Expense: -900205.00
BCTX cash_flow (quarterly, 2025-04-30) — Change In Prepaid Assets: -185969.00
BCTX cash_flow (quarterly, 2025-04-30) — Change In Receivables: -176026.00
BCTX cash_flow (quarterly, 2025-04-30) — Change In Working Capital: -1076231.00
BCTX cash_flow (quarterly, 2025-04-30) — Changes In Cash: 7446599.00
BCTX balance_sheet (quarterly, 2025-04-30) — Common Stock: 94022525.00
BCTX balance_sheet (quarterly, 2025-04-30) — Common Stock Equity: 12415211.00
BCTX cash_flow (quarterly, 2025-04-30) — Common Stock Issuance: 14714376.00
BCTX balance_sheet (quarterly, 2025-04-30) — Current Accrued Expenses: 1051429.00
BCTX balance_sheet (quarterly, 2025-04-30) — Current Assets: 14785198.00
BCTX balance_sheet (quarterly, 2025-04-30) — Current Liabilities: 4330633.00
BCTX cash_flow (quarterly, 2025-04-30) — Depreciation: 22839.00
BCTX cash_flow (quarterly, 2025-04-30) — Depreciation Amortization Depletion: 26656.00
BCTX cash_flow (quarterly, 2025-04-30) — Depreciation And Amortization: 26656.00
BCTX balance_sheet (quarterly, 2025-04-30) — Derivative Product Liabilities: 730012.00
BCTX income_statement (quarterly, 2025-04-30) — Diluted Average Shares: 373067.00
BCTX income_statement (quarterly, 2025-04-30) — Diluted EPS: -16.42
BCTX income_statement (quarterly, 2025-04-30) — Diluted NI Availto Com Stockholders: -6126902.00
BCTX income_statement (quarterly, 2025-04-30) — EBIT: -6187950.00
BCTX income_statement (quarterly, 2025-04-30) — EBITDA: -6161294.00
BCTX income_statement (quarterly, 2025-04-30) — Earnings From Equity Interest: -62738.00
BCTX cash_flow (quarterly, 2025-04-30) — Earnings Losses From Equity Investments: 62738.00
BCTX cash_flow (quarterly, 2025-04-30) — End Cash Position: 12460253.00
BCTX cash_flow (quarterly, 2025-04-30) — Financing Cash Flow: 14714376.00
BCTX cash_flow (quarterly, 2025-04-30) — Free Cash Flow: -7162777.00
BCTX cash_flow (quarterly, 2025-04-30) — Gain Loss On Investment Securities: -175826.00
BCTX income_statement (quarterly, 2025-04-30) — Gain On Sale Of Security: 176411.00
BCTX balance_sheet (quarterly, 2025-04-30) — Gains Losses Not Affecting Retained Earnings: -138684.00
BCTX income_statement (quarterly, 2025-04-30) — General And Administrative Expense: 1518059.00
BCTX balance_sheet (quarterly, 2025-04-30) — Goodwill And Other Intangible Assets: 188343.00
BCTX income_statement (quarterly, 2025-04-30) — Interest Expense: 36979.00
BCTX income_statement (quarterly, 2025-04-30) — Interest Expense Non Operating: 36979.00
BCTX income_statement (quarterly, 2025-04-30) — Interest Income: 26632.00
BCTX income_statement (quarterly, 2025-04-30) — Interest Income Non Operating: 26632.00
BCTX balance_sheet (quarterly, 2025-04-30) — Invested Capital: 12415211.00
BCTX cash_flow (quarterly, 2025-04-30) — Investing Cash Flow: -105000.00
BCTX balance_sheet (quarterly, 2025-04-30) — Investments And Advances: 496653.00
BCTX balance_sheet (quarterly, 2025-04-30) — Investmentsin Subsidiariesat Cost: 496653.00
BCTX cash_flow (quarterly, 2025-04-30) — Issuance Of Capital Stock: 14714376.00
BCTX balance_sheet (quarterly, 2025-04-30) — Long Term Equity Investment: 496653.00
BCTX balance_sheet (quarterly, 2025-04-30) — Minority Interest: -474058.00
BCTX income_statement (quarterly, 2025-04-30) — Minority Interests: 98027.00
BCTX cash_flow (quarterly, 2025-04-30) — Net Business Purchase And Sale: -105000.00
BCTX cash_flow (quarterly, 2025-04-30) — Net Common Stock Issuance: 14714376.00
BCTX income_statement (quarterly, 2025-04-30) — Net Income: -6126902.00
BCTX income_statement (quarterly, 2025-04-30) — Net Income Common Stockholders: -6126902.00
BCTX income_statement (quarterly, 2025-04-30) — Net Income Continuous Operations: -6224929.00
BCTX income_statement (quarterly, 2025-04-30) — Net Income From Continuing And Discontinued Operation: -6126902.00
BCTX income_statement (quarterly, 2025-04-30) — Net Income From Continuing Operation Net Minority Interest: -6126902.00
BCTX cash_flow (quarterly, 2025-04-30) — Net Income From Continuing Operations: -6224929.00
BCTX income_statement (quarterly, 2025-04-30) — Net Income Including Noncontrolling Interests: -6224929.00
BCTX income_statement (quarterly, 2025-04-30) — Net Interest Income: -10347.00
BCTX cash_flow (quarterly, 2025-04-30) — Net Investment Purchase And Sale: 0.00
BCTX income_statement (quarterly, 2025-04-30) — Net Non Operating Interest Income Expense: -10347.00
BCTX balance_sheet (quarterly, 2025-04-30) — Net PPE: 319658.00
BCTX balance_sheet (quarterly, 2025-04-30) — Net Tangible Assets: 12226868.00
BCTX balance_sheet (quarterly, 2025-04-30) — Non Current Prepaid Assets: 1211946.00
BCTX income_statement (quarterly, 2025-04-30) — Normalized EBITDA: -6337705.00
BCTX income_statement (quarterly, 2025-04-30) — Normalized Income: -6303313.00
BCTX cash_flow (quarterly, 2025-04-30) — Operating Cash Flow: -7162777.00
BCTX cash_flow (quarterly, 2025-04-30) — Operating Gains Losses: -113088.00
BCTX income_statement (quarterly, 2025-04-30) — Operating Income: -6328255.00
BCTX income_statement (quarterly, 2025-04-30) — Operating Revenue: 0.00
BCTX balance_sheet (quarterly, 2025-04-30) — Ordinary Shares Number: 655809.00
BCTX balance_sheet (quarterly, 2025-04-30) — Other Equity Adjustments: -138684.00
BCTX balance_sheet (quarterly, 2025-04-30) — Other Equity Interest: 22195564.00
BCTX income_statement (quarterly, 2025-04-30) — Other Gand A: 1518059.00
BCTX income_statement (quarterly, 2025-04-30) — Other Income Expense: 113673.00
BCTX balance_sheet (quarterly, 2025-04-30) — Payables: 3279204.00
BCTX balance_sheet (quarterly, 2025-04-30) — Payables And Accrued Expenses: 4330633.00
BCTX income_statement (quarterly, 2025-04-30) — Pretax Income: -6224929.00
BCTX cash_flow (quarterly, 2025-04-30) — Proceeds From Stock Option Exercised: 0.00
BCTX cash_flow (quarterly, 2025-04-30) — Purchase Of Business: -105000.00
BCTX balance_sheet (quarterly, 2025-04-30) — Receivables: 2324945.00
BCTX income_statement (quarterly, 2025-04-30) — Reconciled Depreciation: 26656.00
BCTX income_statement (quarterly, 2025-04-30) — Research And Development: 4810196.00
BCTX balance_sheet (quarterly, 2025-04-30) — Retained Earnings: -103664194.00
BCTX cash_flow (quarterly, 2025-04-30) — Sale Of Investment: 0.00
BCTX income_statement (quarterly, 2025-04-30) — Selling General And Administration: 1518059.00
BCTX balance_sheet (quarterly, 2025-04-30) — Share Issued: 655809.00
BCTX cash_flow (quarterly, 2025-04-30) — Stock Based Compensation: 224815.00
BCTX balance_sheet (quarterly, 2025-04-30) — Stockholders Equity: 12415211.00
BCTX balance_sheet (quarterly, 2025-04-30) — Tangible Book Value: 12226868.00
BCTX income_statement (quarterly, 2025-04-30) — Tax Effect Of Unusual Items: 0.00
BCTX income_statement (quarterly, 2025-04-30) — Tax Rate For Calcs: 0.00
BCTX balance_sheet (quarterly, 2025-04-30) — Total Assets: 17001798.00
BCTX balance_sheet (quarterly, 2025-04-30) — Total Capitalization: 12415211.00
BCTX balance_sheet (quarterly, 2025-04-30) — Total Equity Gross Minority Interest: 11941153.00
BCTX income_statement (quarterly, 2025-04-30) — Total Expenses: 6328255.00
BCTX balance_sheet (quarterly, 2025-04-30) — Total Liabilities Net Minority Interest: 5060645.00
BCTX balance_sheet (quarterly, 2025-04-30) — Total Non Current Assets: 2216600.00
BCTX balance_sheet (quarterly, 2025-04-30) — Total Non Current Liabilities Net Minority Interest: 730012.00
BCTX income_statement (quarterly, 2025-04-30) — Total Operating Income As Reported: -6328255.00
BCTX income_statement (quarterly, 2025-04-30) — Total Unusual Items: 176411.00
BCTX income_statement (quarterly, 2025-04-30) — Total Unusual Items Excluding Goodwill: 176411.00
BCTX balance_sheet (quarterly, 2025-04-30) — Working Capital: 10454565.00
BCTX income_statement (annual, 2025-07-31) — Basic Average Shares: 423114.00
BCTX income_statement (annual, 2025-07-31) — Basic EPS: -62.19
BCTX income_statement (annual, 2025-07-31) — Diluted Average Shares: 423114.00
BCTX income_statement (annual, 2025-07-31) — Diluted EPS: -62.19
BCTX income_statement (quarterly, 2025-10-31) — +Operating Expense: 8322943.00
BCTX income_statement (quarterly, 2025-10-31) — +Total Revenue: 0.00
BCTX balance_sheet (quarterly, 2025-10-31) — Accounts Payable: 2128915.00
BCTX balance_sheet (quarterly, 2025-10-31) — Accounts Receivable: 1172435.00
BCTX cash_flow (quarterly, 2025-10-31) — Amortization Cash Flow: 3818.00
BCTX cash_flow (quarterly, 2025-10-31) — Amortization Of Intangibles: 3818.00
BCTX income_statement (quarterly, 2025-10-31) — Basic Average Shares: 1883906.00
BCTX income_statement (quarterly, 2025-10-31) — Basic EPS: -4.35
BCTX cash_flow (quarterly, 2025-10-31) — Beginning Cash Position: 10493808.00
BCTX balance_sheet (quarterly, 2025-10-31) — Capital Stock: 101739923.00
BCTX balance_sheet (quarterly, 2025-10-31) — Cash And Cash Equivalents: 2714012.00
BCTX balance_sheet (quarterly, 2025-10-31) — Cash Cash Equivalents And Short Term Investments: 10175972.00
BCTX cash_flow (quarterly, 2025-10-31) — Cash Flow From Continuing Financing Activities: 0.00
BCTX cash_flow (quarterly, 2025-10-31) — Cash Flow From Continuing Investing Activities: -75000.00
BCTX cash_flow (quarterly, 2025-10-31) — Cash Flow From Continuing Operating Activities: -7704796.00
BCTX cash_flow (quarterly, 2025-10-31) — Change In Account Payable: -1154788.00
BCTX cash_flow (quarterly, 2025-10-31) — Change In Accrued Expense: 494573.00
BCTX cash_flow (quarterly, 2025-10-31) — Change In Payable: -1154788.00
BCTX cash_flow (quarterly, 2025-10-31) — Change In Payables And Accrued Expense: -660215.00
BCTX cash_flow (quarterly, 2025-10-31) — Change In Receivables: 887860.00
BCTX cash_flow (quarterly, 2025-10-31) — Change In Working Capital: 227645.00
BCTX cash_flow (quarterly, 2025-10-31) — Changes In Cash: -7779796.00
BCTX balance_sheet (quarterly, 2025-10-31) — Common Stock: 101739923.00
BCTX balance_sheet (quarterly, 2025-10-31) — Common Stock Equity: 9977962.00
BCTX cash_flow (quarterly, 2025-10-31) — Common Stock Issuance: 0.00
BCTX balance_sheet (quarterly, 2025-10-31) — Current Accrued Expenses: 1188858.00
BCTX balance_sheet (quarterly, 2025-10-31) — Current Assets: 11348407.00
BCTX balance_sheet (quarterly, 2025-10-31) — Current Liabilities: 3317773.00
BCTX cash_flow (quarterly, 2025-10-31) — Depreciation: 22839.00
BCTX cash_flow (quarterly, 2025-10-31) — Depreciation Amortization Depletion: 26657.00
BCTX cash_flow (quarterly, 2025-10-31) — Depreciation And Amortization: 26657.00
BCTX balance_sheet (quarterly, 2025-10-31) — Derivative Product Liabilities: 406873.00
BCTX income_statement (quarterly, 2025-10-31) — Diluted Average Shares: 1883906.00
BCTX income_statement (quarterly, 2025-10-31) — Diluted EPS: -4.35
BCTX income_statement (quarterly, 2025-10-31) — Diluted NI Availto Com Stockholders: -8197565.00
BCTX income_statement (quarterly, 2025-10-31) — EBIT: -8322943.00
BCTX income_statement (quarterly, 2025-10-31) — EBITDA: -8296286.00
BCTX income_statement (quarterly, 2025-10-31) — Earnings From Equity Interest: -44830.00
BCTX cash_flow (quarterly, 2025-10-31) — Earnings Losses From Equity Investments: 44830.00
BCTX cash_flow (quarterly, 2025-10-31) — End Cash Position: 2714012.00
BCTX cash_flow (quarterly, 2025-10-31) — Financing Cash Flow: 0.00
BCTX cash_flow (quarterly, 2025-10-31) — Free Cash Flow: -7704796.00
BCTX cash_flow (quarterly, 2025-10-31) — Gain Loss On Investment Securities: 69201.00
BCTX income_statement (quarterly, 2025-10-31) — Gain On Sale Of Security: 40963.00
BCTX balance_sheet (quarterly, 2025-10-31) — Gains Losses Not Affecting Retained Earnings: -138684.00
BCTX income_statement (quarterly, 2025-10-31) — General And Administrative Expense: 1639300.00
BCTX balance_sheet (quarterly, 2025-10-31) — Goodwill And Other Intangible Assets: 180707.00
BCTX income_statement (quarterly, 2025-10-31) — Interest Income: 48482.00
BCTX income_statement (quarterly, 2025-10-31) — Interest Income Non Operating: 48482.00
BCTX balance_sheet (quarterly, 2025-10-31) — Invested Capital: 9977962.00
BCTX cash_flow (quarterly, 2025-10-31) — Investing Cash Flow: -75000.00
BCTX balance_sheet (quarterly, 2025-10-31) — Investments And Advances: 554448.00
BCTX balance_sheet (quarterly, 2025-10-31) — Investmentsin Subsidiariesat Cost: 554448.00
BCTX cash_flow (quarterly, 2025-10-31) — Issuance Of Capital Stock: 0.00
BCTX balance_sheet (quarterly, 2025-10-31) — Long Term Equity Investment: 554448.00
BCTX balance_sheet (quarterly, 2025-10-31) — Minority Interest: -627558.00
BCTX income_statement (quarterly, 2025-10-31) — Minority Interests: 80763.00
BCTX cash_flow (quarterly, 2025-10-31) — Net Business Purchase And Sale: -75000.00
BCTX cash_flow (quarterly, 2025-10-31) — Net Common Stock Issuance: 0.00
BCTX income_statement (quarterly, 2025-10-31) — Net Income: -8197565.00
BCTX income_statement (quarterly, 2025-10-31) — Net Income Common Stockholders: -8197565.00
BCTX income_statement (quarterly, 2025-10-31) — Net Income Continuous Operations: -8278328.00
BCTX income_statement (quarterly, 2025-10-31) — Net Income From Continuing And Discontinued Operation: -8197565.00
BCTX income_statement (quarterly, 2025-10-31) — Net Income From Continuing Operation Net Minority Interest: -8197565.00
BCTX cash_flow (quarterly, 2025-10-31) — Net Income From Continuing Operations: -8278328.00
BCTX income_statement (quarterly, 2025-10-31) — Net Income Including Noncontrolling Interests: -8278328.00
BCTX income_statement (quarterly, 2025-10-31) — Net Interest Income: 48482.00
BCTX income_statement (quarterly, 2025-10-31) — Net Non Operating Interest Income Expense: 48482.00
BCTX balance_sheet (quarterly, 2025-10-31) — Net PPE: 273980.00
BCTX balance_sheet (quarterly, 2025-10-31) — Net Tangible Assets: 9797255.00
BCTX balance_sheet (quarterly, 2025-10-31) — Non Current Prepaid Assets: 717508.00
BCTX income_statement (quarterly, 2025-10-31) — Normalized EBITDA: -8337249.00
BCTX income_statement (quarterly, 2025-10-31) — Normalized Income: -8238528.00
BCTX cash_flow (quarterly, 2025-10-31) — Operating Cash Flow: -7704796.00
BCTX cash_flow (quarterly, 2025-10-31) — Operating Gains Losses: 114031.00
BCTX income_statement (quarterly, 2025-10-31) — Operating Income: -8322943.00
BCTX income_statement (quarterly, 2025-10-31) — Operating Revenue: 0.00
BCTX balance_sheet (quarterly, 2025-10-31) — Ordinary Shares Number: 1883906.00
BCTX balance_sheet (quarterly, 2025-10-31) — Other Equity Adjustments: -138684.00
BCTX balance_sheet (quarterly, 2025-10-31) — Other Equity Interest: 28329852.00
BCTX income_statement (quarterly, 2025-10-31) — Other Gand A: 1639300.00
BCTX income_statement (quarterly, 2025-10-31) — Other Income Expense: -3867.00
BCTX cash_flow (quarterly, 2025-10-31) — Other Non Cash Items: -89487.00
BCTX balance_sheet (quarterly, 2025-10-31) — Other Short Term Investments: 7461960.00
BCTX balance_sheet (quarterly, 2025-10-31) — Payables: 2128915.00
BCTX balance_sheet (quarterly, 2025-10-31) — Payables And Accrued Expenses: 3317773.00
BCTX income_statement (quarterly, 2025-10-31) — Pretax Income: -8278328.00
BCTX cash_flow (quarterly, 2025-10-31) — Proceeds From Stock Option Exercised: 0.00
BCTX cash_flow (quarterly, 2025-10-31) — Purchase Of Business: -75000.00
BCTX balance_sheet (quarterly, 2025-10-31) — Receivables: 1172435.00
BCTX income_statement (quarterly, 2025-10-31) — Reconciled Depreciation: 26657.00
BCTX income_statement (quarterly, 2025-10-31) — Research And Development: 6683643.00
BCTX balance_sheet (quarterly, 2025-10-31) — Retained Earnings: -119953129.00
BCTX income_statement (quarterly, 2025-10-31) — Selling General And Administration: 1639300.00
BCTX balance_sheet (quarterly, 2025-10-31) — Share Issued: 1883906.00
BCTX cash_flow (quarterly, 2025-10-31) — Stock Based Compensation: 294686.00
BCTX balance_sheet (quarterly, 2025-10-31) — Stockholders Equity: 9977962.00
BCTX balance_sheet (quarterly, 2025-10-31) — Tangible Book Value: 9797255.00
BCTX income_statement (quarterly, 2025-10-31) — Tax Effect Of Unusual Items: 0.00
BCTX income_statement (quarterly, 2025-10-31) — Tax Rate For Calcs: 0.00
BCTX balance_sheet (quarterly, 2025-10-31) — Total Assets: 13075050.00
BCTX balance_sheet (quarterly, 2025-10-31) — Total Capitalization: 9977962.00
BCTX balance_sheet (quarterly, 2025-10-31) — Total Equity Gross Minority Interest: 9350404.00
BCTX income_statement (quarterly, 2025-10-31) — Total Expenses: 8322943.00
BCTX balance_sheet (quarterly, 2025-10-31) — Total Liabilities Net Minority Interest: 3724646.00
BCTX balance_sheet (quarterly, 2025-10-31) — Total Non Current Assets: 1726643.00
BCTX balance_sheet (quarterly, 2025-10-31) — Total Non Current Liabilities Net Minority Interest: 406873.00
BCTX income_statement (quarterly, 2025-10-31) — Total Operating Income As Reported: -8322943.00
BCTX income_statement (quarterly, 2025-10-31) — Total Unusual Items: 40963.00
BCTX income_statement (quarterly, 2025-10-31) — Total Unusual Items Excluding Goodwill: 40963.00
BCTX balance_sheet (quarterly, 2025-10-31) — Working Capital: 8030634.00
BCTX income_statement (quarterly, 2026-01-31) — +Operating Expense: 7531266.00
BCTX income_statement (quarterly, 2026-01-31) — +Total Revenue: 0.00
BCTX balance_sheet (quarterly, 2026-01-31) — Accounts Payable: 1879647.00
BCTX balance_sheet (quarterly, 2026-01-31) — Accounts Receivable: 2275256.00
BCTX cash_flow (quarterly, 2026-01-31) — Amortization Cash Flow: 3818.00
BCTX cash_flow (quarterly, 2026-01-31) — Amortization Of Intangibles: 3818.00
BCTX income_statement (quarterly, 2026-01-31) — Basic Average Shares: 2802337.00
BCTX income_statement (quarterly, 2026-01-31) — Basic EPS: -2.58
BCTX cash_flow (quarterly, 2026-01-31) — Beginning Cash Position: 2714012.00
BCTX balance_sheet (quarterly, 2026-01-31) — Capital Stock: 117117225.00
BCTX balance_sheet (quarterly, 2026-01-31) — Cash And Cash Equivalents: 29903628.00
BCTX balance_sheet (quarterly, 2026-01-31) — Cash Cash Equivalents And Short Term Investments: 29903628.00
BCTX cash_flow (quarterly, 2026-01-31) — Cash Flow From Continuing Financing Activities: 27874441.00
BCTX cash_flow (quarterly, 2026-01-31) — Cash Flow From Continuing Investing Activities: 7282473.00
BCTX cash_flow (quarterly, 2026-01-31) — Cash Flow From Continuing Operating Activities: -7967298.00
BCTX cash_flow (quarterly, 2026-01-31) — Change In Account Payable: -249268.00
BCTX cash_flow (quarterly, 2026-01-31) — Change In Accrued Expense: 117045.00
BCTX cash_flow (quarterly, 2026-01-31) — Change In Payable: -249268.00
BCTX cash_flow (quarterly, 2026-01-31) — Change In Payables And Accrued Expense: -132223.00
BCTX cash_flow (quarterly, 2026-01-31) — Change In Receivables: -790398.00
BCTX cash_flow (quarterly, 2026-01-31) — Change In Working Capital: -922621.00
BCTX cash_flow (quarterly, 2026-01-31) — Changes In Cash: 27189616.00
BCTX balance_sheet (quarterly, 2026-01-31) — Common Stock: 117117225.00
BCTX balance_sheet (quarterly, 2026-01-31) — Common Stock Equity: 30916439.00
BCTX cash_flow (quarterly, 2026-01-31) — Common Stock Issuance: 27874441.00
BCTX balance_sheet (quarterly, 2026-01-31) — Current Accrued Expenses: 1305903.00
BCTX balance_sheet (quarterly, 2026-01-31) — Current Assets: 32178884.00
BCTX balance_sheet (quarterly, 2026-01-31) — Current Liabilities: 3185550.00
BCTX cash_flow (quarterly, 2026-01-31) — Depreciation: 22839.00
BCTX cash_flow (quarterly, 2026-01-31) — Depreciation Amortization Depletion: 26657.00
BCTX cash_flow (quarterly, 2026-01-31) — Depreciation And Amortization: 26657.00
BCTX balance_sheet (quarterly, 2026-01-31) — Derivative Product Liabilities: 195096.00
BCTX income_statement (quarterly, 2026-01-31) — Diluted Average Shares: 2802337.00
BCTX income_statement (quarterly, 2026-01-31) — Diluted EPS: -2.58
BCTX income_statement (quarterly, 2026-01-31) — Diluted NI Availto Com Stockholders: -7221820.00
BCTX income_statement (quarterly, 2026-01-31) — EBIT: -7531266.00
BCTX income_statement (quarterly, 2026-01-31) — EBITDA: -7504609.00
BCTX income_statement (quarterly, 2026-01-31) — Earnings From Equity Interest: -61993.00
BCTX cash_flow (quarterly, 2026-01-31) — Earnings Losses From Equity Investments: 61993.00
BCTX cash_flow (quarterly, 2026-01-31) — End Cash Position: 29903628.00
BCTX cash_flow (quarterly, 2026-01-31) — Financing Cash Flow: 27874441.00
BCTX cash_flow (quarterly, 2026-01-31) — Free Cash Flow: -7967298.00
BCTX cash_flow (quarterly, 2026-01-31) — Gain Loss On Investment Securities: -211777.00
BCTX income_statement (quarterly, 2026-01-31) — Gain On Sale Of Security: 190728.00
BCTX balance_sheet (quarterly, 2026-01-31) — Gains Losses Not Affecting Retained Earnings: -138684.00
BCTX income_statement (quarterly, 2026-01-31) — General And Administrative Expense: 1477577.00
BCTX balance_sheet (quarterly, 2026-01-31) — Goodwill And Other Intangible Assets: 176889.00
BCTX income_statement (quarterly, 2026-01-31) — Interest Income: 105638.00
BCTX income_statement (quarterly, 2026-01-31) — Interest Income Non Operating: 105638.00
BCTX balance_sheet (quarterly, 2026-01-31) — Invested Capital: 30916439.00
BCTX cash_flow (quarterly, 2026-01-31) — Investing Cash Flow: 7282473.00
BCTX balance_sheet (quarterly, 2026-01-31) — Investments And Advances: 582455.00
BCTX balance_sheet (quarterly, 2026-01-31) — Investmentsin Subsidiariesat Cost: 582455.00
BCTX cash_flow (quarterly, 2026-01-31) — Issuance Of Capital Stock: 27874441.00
BCTX balance_sheet (quarterly, 2026-01-31) — Long Term Equity Investment: 582455.00
BCTX balance_sheet (quarterly, 2026-01-31) — Minority Interest: -702631.00
BCTX income_statement (quarterly, 2026-01-31) — Minority Interests: 75073.00
BCTX cash_flow (quarterly, 2026-01-31) — Net Business Purchase And Sale: -90000.00
BCTX cash_flow (quarterly, 2026-01-31) — Net Common Stock Issuance: 27874441.00
BCTX income_statement (quarterly, 2026-01-31) — Net Income: -7221820.00
BCTX income_statement (quarterly, 2026-01-31) — Net Income Common Stockholders: -7221820.00
BCTX income_statement (quarterly, 2026-01-31) — Net Income Continuous Operations: -7296893.00
BCTX income_statement (quarterly, 2026-01-31) — Net Income From Continuing And Discontinued Operation: -7221820.00
BCTX income_statement (quarterly, 2026-01-31) — Net Income From Continuing Operation Net Minority Interest: -7221820.00
BCTX cash_flow (quarterly, 2026-01-31) — Net Income From Continuing Operations: -7296893.00
BCTX income_statement (quarterly, 2026-01-31) — Net Income Including Noncontrolling Interests: -7296893.00
BCTX income_statement (quarterly, 2026-01-31) — Net Interest Income: 105638.00
BCTX income_statement (quarterly, 2026-01-31) — Net Non Operating Interest Income Expense: 105638.00
BCTX balance_sheet (quarterly, 2026-01-31) — Net PPE: 251141.00
BCTX balance_sheet (quarterly, 2026-01-31) — Net Tangible Assets: 30739550.00
BCTX balance_sheet (quarterly, 2026-01-31) — Non Current Prepaid Assets: 405085.00
BCTX income_statement (quarterly, 2026-01-31) — Normalized EBITDA: -7695337.00
BCTX income_statement (quarterly, 2026-01-31) — Normalized Income: -7412548.00
BCTX cash_flow (quarterly, 2026-01-31) — Operating Cash Flow: -7967298.00
BCTX cash_flow (quarterly, 2026-01-31) — Operating Gains Losses: -149784.00
BCTX income_statement (quarterly, 2026-01-31) — Operating Income: -7531266.00
BCTX income_statement (quarterly, 2026-01-31) — Operating Revenue: 0.00
BCTX balance_sheet (quarterly, 2026-01-31) — Ordinary Shares Number: 7250487.00
BCTX balance_sheet (quarterly, 2026-01-31) — Other Equity Adjustments: -138684.00
BCTX balance_sheet (quarterly, 2026-01-31) — Other Equity Interest: 41112847.00
BCTX income_statement (quarterly, 2026-01-31) — Other Gand A: 1477577.00
BCTX income_statement (quarterly, 2026-01-31) — Other Income Expense: 128735.00
BCTX balance_sheet (quarterly, 2026-01-31) — Other Short Term Investments: 0.00
BCTX balance_sheet (quarterly, 2026-01-31) — Payables: 1879647.00
BCTX balance_sheet (quarterly, 2026-01-31) — Payables And Accrued Expenses: 3185550.00
BCTX income_statement (quarterly, 2026-01-31) — Pretax Income: -7296893.00
BCTX cash_flow (quarterly, 2026-01-31) — Proceeds From Stock Option Exercised: 0.00
BCTX cash_flow (quarterly, 2026-01-31) — Purchase Of Business: -90000.00
BCTX balance_sheet (quarterly, 2026-01-31) — Receivables: 2275256.00
BCTX income_statement (quarterly, 2026-01-31) — Reconciled Depreciation: 26657.00
BCTX income_statement (quarterly, 2026-01-31) — Research And Development: 6053689.00
BCTX balance_sheet (quarterly, 2026-01-31) — Retained Earnings: -127174949.00
BCTX income_statement (quarterly, 2026-01-31) — Selling General And Administration: 1477577.00
BCTX balance_sheet (quarterly, 2026-01-31) — Share Issued: 7250487.00
BCTX cash_flow (quarterly, 2026-01-31) — Stock Based Compensation: 285856.00
BCTX balance_sheet (quarterly, 2026-01-31) — Stockholders Equity: 30916439.00
BCTX balance_sheet (quarterly, 2026-01-31) — Tangible Book Value: 30739550.00
BCTX income_statement (quarterly, 2026-01-31) — Tax Effect Of Unusual Items: 0.00
BCTX income_statement (quarterly, 2026-01-31) — Tax Rate For Calcs: 0.00
BCTX balance_sheet (quarterly, 2026-01-31) — Total Assets: 33594454.00
BCTX balance_sheet (quarterly, 2026-01-31) — Total Capitalization: 30916439.00
BCTX balance_sheet (quarterly, 2026-01-31) — Total Equity Gross Minority Interest: 30213808.00
BCTX income_statement (quarterly, 2026-01-31) — Total Expenses: 7531266.00
BCTX balance_sheet (quarterly, 2026-01-31) — Total Liabilities Net Minority Interest: 3380646.00
BCTX balance_sheet (quarterly, 2026-01-31) — Total Non Current Assets: 1415570.00
BCTX balance_sheet (quarterly, 2026-01-31) — Total Non Current Liabilities Net Minority Interest: 195096.00
BCTX income_statement (quarterly, 2026-01-31) — Total Operating Income As Reported: -7531266.00
BCTX income_statement (quarterly, 2026-01-31) — Total Unusual Items: 190728.00
BCTX income_statement (quarterly, 2026-01-31) — Total Unusual Items Excluding Goodwill: 190728.00
BCTX balance_sheet (quarterly, 2026-01-31) — Working Capital: 28993334.00
BCTX income_statement (quarterly, 2026-04-30) — +Operating Expense: 7620794.00
BCTX income_statement (quarterly, 2026-04-30) — +Total Revenue: 0.00
BCTX balance_sheet (quarterly, 2026-04-30) — Accounts Payable: 2174437.00
BCTX balance_sheet (quarterly, 2026-04-30) — Accounts Receivable: 2588749.00
BCTX cash_flow (quarterly, 2026-04-30) — Amortization Cash Flow: 3817.00
BCTX cash_flow (quarterly, 2026-04-30) — Amortization Of Intangibles: 3817.00
BCTX income_statement (quarterly, 2026-04-30) — Basic Average Shares: 7250487.00
BCTX income_statement (quarterly, 2026-04-30) — Basic EPS: -0.99
BCTX cash_flow (quarterly, 2026-04-30) — Beginning Cash Position: 29903628.00
BCTX balance_sheet (quarterly, 2026-04-30) — Capital Stock: 117117225.00
BCTX balance_sheet (quarterly, 2026-04-30) — Cash And Cash Equivalents: 6880221.00
BCTX balance_sheet (quarterly, 2026-04-30) — Cash Cash Equivalents And Short Term Investments: 22804425.00
BCTX cash_flow (quarterly, 2026-04-30) — Cash Flow From Continuing Financing Activities: 0.00
BCTX cash_flow (quarterly, 2026-04-30) — Cash Flow From Continuing Investing Activities: -16003049.00
BCTX cash_flow (quarterly, 2026-04-30) — Cash Flow From Continuing Operating Activities: -7020358.00
BCTX cash_flow (quarterly, 2026-04-30) — Change In Account Payable: 294790.00
BCTX cash_flow (quarterly, 2026-04-30) — Change In Accrued Expense: 110156.00
BCTX cash_flow (quarterly, 2026-04-30) — Change In Payable: 294790.00
BCTX cash_flow (quarterly, 2026-04-30) — Change In Payables And Accrued Expense: 404946.00
BCTX cash_flow (quarterly, 2026-04-30) — Change In Receivables: -313493.00
BCTX cash_flow (quarterly, 2026-04-30) — Change In Working Capital: 91453.00
BCTX cash_flow (quarterly, 2026-04-30) — Changes In Cash: -23023407.00
BCTX balance_sheet (quarterly, 2026-04-30) — Common Stock: 117117225.00
BCTX balance_sheet (quarterly, 2026-04-30) — Common Stock Equity: 24058059.00
BCTX cash_flow (quarterly, 2026-04-30) — Common Stock Issuance: 0.00
BCTX balance_sheet (quarterly, 2026-04-30) — Current Accrued Expenses: 1416059.00
BCTX balance_sheet (quarterly, 2026-04-30) — Current Assets: 25393174.00
BCTX balance_sheet (quarterly, 2026-04-30) — Current Liabilities: 3590496.00
BCTX cash_flow (quarterly, 2026-04-30) — Depreciation: 29193.00
BCTX cash_flow (quarterly, 2026-04-30) — Depreciation Amortization Depletion: 33010.00
BCTX cash_flow (quarterly, 2026-04-30) — Depreciation And Amortization: 33010.00
BCTX balance_sheet (quarterly, 2026-04-30) — Derivative Product Liabilities: 71854.00
BCTX income_statement (quarterly, 2026-04-30) — Diluted Average Shares: 7250487.00
BCTX income_statement (quarterly, 2026-04-30) — Diluted EPS: -0.99
BCTX income_statement (quarterly, 2026-04-30) — Diluted NI Availto Com Stockholders: -7164507.00
BCTX income_statement (quarterly, 2026-04-30) — EBIT: -7207424.00
BCTX income_statement (quarterly, 2026-04-30) — EBITDA: -7174414.00
BCTX income_statement (quarterly, 2026-04-30) — Earnings From Equity Interest: -64303.00
BCTX cash_flow (quarterly, 2026-04-30) — Earnings Losses From Equity Investments: 64303.00
BCTX cash_flow (quarterly, 2026-04-30) — End Cash Position: 6880221.00
BCTX cash_flow (quarterly, 2026-04-30) — Financing Cash Flow: 0.00
BCTX cash_flow (quarterly, 2026-04-30) — Free Cash Flow: -7147407.00
BCTX cash_flow (quarterly, 2026-04-30) — Gain Loss On Investment Securities: -261072.00
BCTX income_statement (quarterly, 2026-04-30) — Gain On Sale Of Security: 258453.00
BCTX balance_sheet (quarterly, 2026-04-30) — Gains Losses Not Affecting Retained Earnings: -138684.00
BCTX income_statement (quarterly, 2026-04-30) — General And Administrative Expense: 1654121.00
BCTX balance_sheet (quarterly, 2026-04-30) — Goodwill And Other Intangible Assets: 173072.00
BCTX income_statement (quarterly, 2026-04-30) — Interest Expense: 29631.00
BCTX income_statement (quarterly, 2026-04-30) — Interest Expense Non Operating: 29631.00
BCTX income_statement (quarterly, 2026-04-30) — Interest Income: 219220.00
BCTX income_statement (quarterly, 2026-04-30) — Interest Income Non Operating: 219220.00
BCTX balance_sheet (quarterly, 2026-04-30) — Invested Capital: 24058059.00
BCTX cash_flow (quarterly, 2026-04-30) — Investing Cash Flow: -16003049.00
BCTX balance_sheet (quarterly, 2026-04-30) — Investments And Advances: 750982.00
BCTX balance_sheet (quarterly, 2026-04-30) — Investmentsin Subsidiariesat Cost: 750982.00
BCTX cash_flow (quarterly, 2026-04-30) — Issuance Of Capital Stock: 0.00
BCTX balance_sheet (quarterly, 2026-04-30) — Long Term Equity Investment: 750982.00
BCTX balance_sheet (quarterly, 2026-04-30) — Minority Interest: -649099.00
BCTX income_statement (quarterly, 2026-04-30) — Minority Interests: 72548.00
BCTX cash_flow (quarterly, 2026-04-30) — Net Business Purchase And Sale: -95000.00
BCTX cash_flow (quarterly, 2026-04-30) — Net Common Stock Issuance: 0.00
BCTX income_statement (quarterly, 2026-04-30) — Net Income: -7164507.00
BCTX income_statement (quarterly, 2026-04-30) — Net Income Common Stockholders: -7164507.00
BCTX income_statement (quarterly, 2026-04-30) — Net Income Continuous Operations: -7237055.00
BCTX income_statement (quarterly, 2026-04-30) — Net Income From Continuing And Discontinued Operation: -7164507.00
BCTX income_statement (quarterly, 2026-04-30) — Net Income From Continuing Operation Net Minority Interest: -7164507.00
BCTX cash_flow (quarterly, 2026-04-30) — Net Income From Continuing Operations: -7237055.00
BCTX income_statement (quarterly, 2026-04-30) — Net Income Including Noncontrolling Interests: -7237055.00
BCTX income_statement (quarterly, 2026-04-30) — Net Interest Income: 189589.00
BCTX cash_flow (quarterly, 2026-04-30) — Net Investment Purchase And Sale: -15781000.00
BCTX income_statement (quarterly, 2026-04-30) — Net Non Operating Interest Income Expense: 189589.00
BCTX balance_sheet (quarterly, 2026-04-30) — Net PPE: 348997.00
BCTX balance_sheet (quarterly, 2026-04-30) — Net Tangible Assets: 23884987.00
BCTX balance_sheet (quarterly, 2026-04-30) — Non Current Prepaid Assets: 405085.00
BCTX income_statement (quarterly, 2026-04-30) — Normalized EBITDA: -7432867.00
BCTX income_statement (quarterly, 2026-04-30) — Normalized Income: -7422960.00
BCTX cash_flow (quarterly, 2026-04-30) — Operating Cash Flow: -7020358.00
BCTX cash_flow (quarterly, 2026-04-30) — Operating Gains Losses: -196769.00
BCTX income_statement (quarterly, 2026-04-30) — Operating Income: -7620794.00
BCTX income_statement (quarterly, 2026-04-30) — Operating Revenue: 0.00
BCTX balance_sheet (quarterly, 2026-04-30) — Ordinary Shares Number: 7250487.00
BCTX balance_sheet (quarterly, 2026-04-30) — Other Equity Adjustments: -138684.00
BCTX balance_sheet (quarterly, 2026-04-30) — Other Equity Interest: 41418974.00
BCTX income_statement (quarterly, 2026-04-30) — Other Gand A: 1654121.00
BCTX income_statement (quarterly, 2026-04-30) — Other Income Expense: 194150.00
BCTX balance_sheet (quarterly, 2026-04-30) — Other Short Term Investments: 15924204.00
BCTX balance_sheet (quarterly, 2026-04-30) — Payables: 2174437.00
BCTX balance_sheet (quarterly, 2026-04-30) — Payables And Accrued Expenses: 3590496.00
BCTX income_statement (quarterly, 2026-04-30) — Pretax Income: -7237055.00
BCTX cash_flow (quarterly, 2026-04-30) — Proceeds From Stock Option Exercised: 0.00
BCTX cash_flow (quarterly, 2026-04-30) — Purchase Of Business: -95000.00
BCTX balance_sheet (quarterly, 2026-04-30) — Receivables: 2588749.00
BCTX income_statement (quarterly, 2026-04-30) — Reconciled Depreciation: 33010.00
BCTX income_statement (quarterly, 2026-04-30) — Research And Development: 5966673.00
BCTX balance_sheet (quarterly, 2026-04-30) — Retained Earnings: -134339456.00
BCTX cash_flow (quarterly, 2026-04-30) — Sale Of Investment: 0.00
BCTX income_statement (quarterly, 2026-04-30) — Selling General And Administration: 1654121.00
BCTX balance_sheet (quarterly, 2026-04-30) — Share Issued: 7250487.00
BCTX cash_flow (quarterly, 2026-04-30) — Stock Based Compensation: 432207.00
BCTX balance_sheet (quarterly, 2026-04-30) — Stockholders Equity: 24058059.00
BCTX balance_sheet (quarterly, 2026-04-30) — Tangible Book Value: 23884987.00
BCTX income_statement (quarterly, 2026-04-30) — Tax Effect Of Unusual Items: 0.00
BCTX income_statement (quarterly, 2026-04-30) — Tax Rate For Calcs: 0.00
BCTX balance_sheet (quarterly, 2026-04-30) — Total Assets: 27071310.00
BCTX balance_sheet (quarterly, 2026-04-30) — Total Capitalization: 24058059.00
BCTX balance_sheet (quarterly, 2026-04-30) — Total Equity Gross Minority Interest: 23408960.00
BCTX income_statement (quarterly, 2026-04-30) — Total Expenses: 7620794.00
BCTX balance_sheet (quarterly, 2026-04-30) — Total Liabilities Net Minority Interest: 3662350.00
BCTX balance_sheet (quarterly, 2026-04-30) — Total Non Current Assets: 1678136.00
BCTX balance_sheet (quarterly, 2026-04-30) — Total Non Current Liabilities Net Minority Interest: 71854.00
BCTX income_statement (quarterly, 2026-04-30) — Total Operating Income As Reported: -7620794.00
BCTX income_statement (quarterly, 2026-04-30) — Total Unusual Items: 258453.00
BCTX income_statement (quarterly, 2026-04-30) — Total Unusual Items Excluding Goodwill: 258453.00
BCTX balance_sheet (quarterly, 2026-04-30) — Working Capital: 21802678.00
BCTXZ income_statement (annual, 2021-07-31) — +Operating Expense: 6972344.00
BCTXZ income_statement (annual, 2021-07-31) — +Total Revenue: 0.00
BCTXZ balance_sheet (annual, 2021-07-31) — Accounts Payable: 214116.00
BCTXZ balance_sheet (annual, 2021-07-31) — Accounts Receivable: 12574.00
BCTXZ balance_sheet (annual, 2021-07-31) — Additional Paid In Capital: 2178130.00
BCTXZ income_statement (annual, 2021-07-31) — Amortization: 15254.00
BCTXZ income_statement (annual, 2021-07-31) — Amortization Of Intangibles Income Statement: 15254.00
BCTXZ cash_flow (annual, 2021-07-31) — Beginning Cash Position: 21249.00
BCTXZ balance_sheet (annual, 2021-07-31) — Capital Stock: 54774172.00
BCTXZ balance_sheet (annual, 2021-07-31) — Cash And Cash Equivalents: 57268685.00
BCTXZ balance_sheet (annual, 2021-07-31) — Cash Cash Equivalents And Short Term Investments: 57268685.00
BCTXZ balance_sheet (annual, 2021-07-31) — Cash Financial: 57268685.00
BCTXZ cash_flow (annual, 2021-07-31) — Cash Flow From Continuing Financing Activities: 64997624.00
BCTXZ cash_flow (annual, 2021-07-31) — Cash Flow From Continuing Investing Activities: 0.00
BCTXZ cash_flow (annual, 2021-07-31) — Cash Flow From Continuing Operating Activities: -7750188.00
BCTXZ cash_flow (annual, 2021-07-31) — Change In Account Payable: -1405664.00
BCTXZ cash_flow (annual, 2021-07-31) — Change In Accrued Expense: -785399.00
BCTXZ cash_flow (annual, 2021-07-31) — Change In Payable: -1405664.00
BCTXZ cash_flow (annual, 2021-07-31) — Change In Payables And Accrued Expense: -2191063.00
BCTXZ cash_flow (annual, 2021-07-31) — Change In Prepaid Assets: -100984.00
BCTXZ cash_flow (annual, 2021-07-31) — Change In Receivables: 9941.00
BCTXZ cash_flow (annual, 2021-07-31) — Change In Working Capital: -2282106.00
BCTXZ cash_flow (annual, 2021-07-31) — Changes In Cash: 57247436.00
BCTXZ balance_sheet (annual, 2021-07-31) — Common Stock: 54774172.00
BCTXZ balance_sheet (annual, 2021-07-31) — Common Stock Equity: 27671721.00
BCTXZ cash_flow (annual, 2021-07-31) — Common Stock Issuance: 51622337.00
BCTXZ cash_flow (annual, 2021-07-31) — Common Stock Payments: 0.00
BCTXZ balance_sheet (annual, 2021-07-31) — Current Accrued Expenses: 261712.00
BCTXZ balance_sheet (annual, 2021-07-31) — Current Assets: 57798150.00
BCTXZ balance_sheet (annual, 2021-07-31) — Current Liabilities: 556795.00
BCTXZ cash_flow (annual, 2021-07-31) — Depreciation Amortization Depletion: 15256.00
BCTXZ income_statement (annual, 2021-07-31) — Depreciation Amortization Depletion Income Statement: 15254.00
BCTXZ cash_flow (annual, 2021-07-31) — Depreciation And Amortization: 15256.00
BCTXZ income_statement (annual, 2021-07-31) — Depreciation And Amortization In Income Statement: 15254.00
BCTXZ income_statement (annual, 2021-07-31) — Depreciation Income Statement: 15254.00
BCTXZ balance_sheet (annual, 2021-07-31) — Derivative Product Liabilities: 29789260.00
BCTXZ income_statement (annual, 2021-07-31) — Diluted NI Availto Com Stockholders: -13816200.00
BCTXZ income_statement (annual, 2021-07-31) — EBIT: -13737646.00
BCTXZ income_statement (annual, 2021-07-31) — EBITDA: -13722390.00
BCTXZ cash_flow (annual, 2021-07-31) — Effect Of Exchange Rate Changes: 0.00
BCTXZ cash_flow (annual, 2021-07-31) — End Cash Position: 57268685.00
BCTXZ cash_flow (annual, 2021-07-31) — Financing Cash Flow: 64997624.00
BCTXZ cash_flow (annual, 2021-07-31) — Free Cash Flow: -7750188.00
BCTXZ cash_flow (annual, 2021-07-31) — Gain Loss On Investment Securities: 4448957.00
BCTXZ income_statement (annual, 2021-07-31) — Gain On Sale Of Security: -6626748.00
BCTXZ balance_sheet (annual, 2021-07-31) — Gains Losses Not Affecting Retained Earnings: -138684.00
BCTXZ income_statement (annual, 2021-07-31) — General And Administrative Expense: 4955136.00
BCTXZ balance_sheet (annual, 2021-07-31) — Goodwill And Other Intangible Assets: 245610.00
BCTXZ income_statement (annual, 2021-07-31) — Insurance And Claims: 318034.00
BCTXZ income_statement (annual, 2021-07-31) — Interest Expense: 78554.00
BCTXZ income_statement (annual, 2021-07-31) — Interest Expense Non Operating: 78554.00
BCTXZ income_statement (annual, 2021-07-31) — Interest Income: 3149.00
BCTXZ income_statement (annual, 2021-07-31) — Interest Income Non Operating: 3149.00
BCTXZ balance_sheet (annual, 2021-07-31) — Invested Capital: 27697707.00
BCTXZ cash_flow (annual, 2021-07-31) — Investing Cash Flow: 0.00
BCTXZ balance_sheet (annual, 2021-07-31) — Investments And Advances: 2.00